Quantified Launches New AI Sales Coaching Platform to Transform How Life Sciences Teams Prepare, Coach, and Win

Why It Matters

The platform bridges the gap between compliance‑heavy training and real‑time sales execution, giving pharma firms a scalable way to boost rep effectiveness while staying within strict regulatory limits. Its measurable impact on readiness and outcomes positions AI‑driven coaching as a competitive differentiator in the life‑sciences market.

Key Takeaways

• Quantified's platform adds six AI agents covering full rep lifecycle.
• Adaptive AI personalizes coaching based on role, tenure, and proficiency.
• Customers see 6x practice increase, 40% faster readiness, 19% better outcomes.
• Platform includes compliance guardrails meeting OPDP and pharma regulations.
• Deployed with 30+ enterprises, including 10 top pharma firms.

Pulse Analysis

Life‑sciences sales teams operate under intense regulatory scrutiny, making traditional training both costly and risky. Quantified’s new platform addresses this by embedding compliance directly into the coaching workflow, leveraging a private, fine‑tuned AI model that respects OPDP guidelines. By moving beyond one‑off role‑play sessions, the solution creates a continuous learning loop where reps can rehearse, receive real‑time feedback, and refine messaging without jeopardizing compliance, a critical advantage for pharmaceutical giants navigating ever‑tightening oversight.

At the heart of the offering is Adaptive AI, which dynamically adjusts coaching pathways based on each rep’s experience, performance data, and business context. The six AI agents—Roleplay, Readiness Coach, Authoring, Field Coach, Compliance, and Insights—work in concert to cover the entire sales lifecycle, from onboarding to post‑call debriefs. This modular architecture not only accelerates skill acquisition, cutting time‑to‑proficiency by roughly 40%, but also generates granular metrics that link coaching activity to revenue outcomes, enabling managers to pinpoint gaps and allocate resources with surgical precision.

The market implications are significant. With more than 30 enterprise customers, including ten of the world’s largest pharma firms, Quantified is positioning itself as a de‑facto system of record for commercial readiness in a sector where every conversation can affect market share and regulatory risk. Competitors that rely on generic AI tools may struggle to meet the same compliance standards, giving Quantified a defensible moat. As AI adoption accelerates across the broader sales tech stack, platforms that combine regulatory fidelity with measurable performance gains are likely to become the benchmark for future sales enablement investments.